Nih
Nih funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
RFA-DC-25-003: Cooperative Agreement for In Vivo High-Resolution Inner Ear Imaging (U01, Clinical Trial Required)
NIH/NIDCD funding for investigator-initiated high-risk clinical trials that advance non-invasive in vivo imaging of the inner ear and support translation of imaging technologies into clinical care.
RFA-DC-25-005: In Vivo High-Resolution Imaging for Inner Ear Visualization (R01, Clinical Trial Optional)
This NIH NIDCD RFA funds projects that develop higher-resolution structural or functional imaging for the living human inner ear, with up to $500,000 direct costs per year and FY 2026/2027 allocations.
RFA-DC-26-001: Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)
NIH's NIDCD reissue asks for early-stage dissemination and implementation (D&I) research to move evidence-based communication-disorder interventions toward real-world use through a two-year, R21-format mechanism.
RFA-DC-27-004: BRAIN Initiative Exploratory Research Opportunities Using Invasive Neural Recording and Stimulation in the Human Brain (R61)
NIH BRAIN Initiative award for exploratory in vivo human neuroscience research using invasive recording and stimulation, with no clinical trials, up to $700,000 direct costs per year and a 3-year maximum project period.
RFA-DE-27-001: Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed)
The NIH/NIDCR 2027 funding cycle call seeks one U01 cooperative agreement to run the CEED hub that coordinates community-engaged oral health research and data infrastructure for the ADAPT consortium.
RFA-DE-27-002: Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx) (U24 Clinical Trial Not Allowed)
NIH Notice of Funding Opportunity to build a U24 Tissue Engineering and Regenerative Medicine Resource Center with an initial cohort of Interdisciplinary Translational Projects focused on pre-clinical de-risking and FDA-oriented readiness.
RFA-DK-26-315: Advancing Research on Digital Health Technology for Type 2 Diabetes (R01)
NIH RFA-DK-26-315 is a clinical-trial R01 opportunity for U.S. institutions to test digital health approaches to improve type 2 diabetes management, with submission cycles in 2026 and 2027 and a strict non-responsiveness rule against tool-building and T1D-only projects.
RFA-DK-27-126: Kidney, Urologic, and Hematologic Diseases - Fostering the AdvanceMent of an Interactive Learning Community (KUH-FAMILY) (U24 Clinical Trials Not Allowed)
NIH is seeking one RFA-DK-27-126 cooperative agreement to establish a coordinating center that builds a sustained translational learning ecosystem for kidney, urologic, and hematologic disease research through shared clinical and data infrastructure.
RFA-ES-25-002: Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)
NIH's RFA-ES-25-002 invites U.S. institutions to build environmental health sciences core center infrastructure (P30), with recurring due dates in 2026 and 2027 for a long-cycle, multi-disciplinary research program.
RFA-ES-27-004: Superfund Hazardous Substance Research and Training Program (P42, Clinical Trial Optional)
NIEHS is continuing its Superfund Hazardous Substance Research and Training Program (SRP) through a multiproject P42 mechanism to fund interdisciplinary center-based hazardous substances research and training across detection, risk assessment, exposure science, and toxicity reduction.